Cytometry investigation of myo-inositol-induced growth inhibition, apoptosis induction and cell cycle arrest in the human prostate cancer cell line (DU-145).

Authors

  • M J Islam Associate Professor of Pharmacology, Bangabandhu Sheikh Mujib University (BSMMU), Dhaka, Bangladesh
  • Adhir Kumar Das Professor of Pharmacology, Bangabandhu Sheikh Mujib University (BSMMU), Dhaka, Bangladesh
  • Muntaha S Lecturer, Shahabuddin Medical College, Gulshan, Dhaka

DOI:

https://doi.org/10.3329/bjms.v23i3.75021

Keywords:

Myo-inositol; Apoptosis; cell cycle arrest; Cancer- chemoprevention.

Abstract

Background The study aimed to study the relative and absolute indicators of liver cancer (C22) in Kazakhstan over 10 years in the prism of a trend indicator (moving average), coefficient of variation (Cv), accounting reliability index (Idi).In 2022, in Kazakhstan, the incidence of liver cancer (C22) was 5.1 per 100 thousand people, mortality was 2.9, respectively, the index of reliability of accounting was 0.2.The unified risk of morbidity of the population of Kazakhstan with liver cancer for the period 2013-2022 amounted to 28.6%, mortality - 33.5%, respectively.

Result Over the period 2013-2022, newly diagnosed liver cancer in Kazakhstan increased by 31%, the rate of decrease in the number of newly diagnosed liver cancers varied unevenly over the years, which demonstrates a high rate and amplitude of change from 105 to -140, which significantly complicates the prediction of this pathology.

Conclusion: For the period 2013-2022, posthumously registered liver cancer consistently occupied the first place in the structure of specific gravity among all malignant neoplasms in Kazakhstan.  

Bangladesh Journal of Medical Science Vol. 23 No. 03 July’24 Page : 655-665

Downloads

Download data is not yet available.
Abstract
189
PDF
314

Downloads

Published

2024-07-29

How to Cite

Islam, M. J., Das, A. K., & S, M. (2024). Cytometry investigation of myo-inositol-induced growth inhibition, apoptosis induction and cell cycle arrest in the human prostate cancer cell line (DU-145) . Bangladesh Journal of Medical Science, 23(3), 655–665. https://doi.org/10.3329/bjms.v23i3.75021

Issue

Vol. 23 No. 3 (2024)

Section

Original Articles

License

Copyright (c) 2024 M J Islam, Adhir Kumar Das, Muntaha S

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.